Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -61.69 Thousand USD | 97.05% |
| 2019 | -264.15 Thousand USD | 75.33% |
| 2018 | -559.03 Thousand USD | 62.16% |
| 2017 | -876.34 Thousand USD | -10.11% |
| 2016 | -6.38 Million USD | -136984.86% |
| 2015 | -2.16 Million USD | 98.69% |
| 2014 | -519.1 Thousand USD | 17.63% |
| 2013 | -483.53 Thousand USD | 16.18% |
| 2012 | -556.91 Thousand USD | 42.21% |
| 2011 | -27.65 Million USD | 50.42% |
| 2010 | -1.65 Million USD | -6734.64% |
| 2009 | -337.75 Thousand USD | 99.94% |
| 2008 | -12.09 Million USD | -731.33% |
| 2007 | -1.4 Million USD | -81.66% |
| 2006 | -1.17 Million USD | -53.26% |
| 2005 | -931.49 Thousand USD | -45.53% |
| 2004 | -660.3 Thousand USD | 0.0% |
| 2002 | -89.24 Thousand USD | 23.19% |
| 2001 | -116.18 Thousand USD | -1551.35% |
| 2000 | -7035.53 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | -25.84 Thousand USD | 92.17% |
| 2021 Q1 | -52.83 Thousand USD | -114.41% |
| 2021 Q2 | -330.07 Thousand USD | -524.67% |
| 2021 FY | - USD | 100.0% |
| 2020 Q4 | 366.56 Thousand USD | 178.21% |
| 2020 Q1 | 123.21 Thousand USD | 128.6% |
| 2020 Q2 | -30.07 Thousand USD | -124.41% |
| 2020 Q3 | -468.7 Thousand USD | -1458.62% |
| 2020 FY | - USD | 97.05% |
| 2019 Q2 | 252.91 Thousand USD | 662.23% |
| 2019 FY | - USD | 75.33% |
| 2019 Q1 | 33.18 Thousand USD | 105.35% |
| 2019 Q3 | -160.75 Thousand USD | -163.56% |
| 2019 Q4 | -430.75 Thousand USD | -167.96% |
| 2018 FY | - USD | 62.16% |
| 2018 Q4 | -619.88 Thousand USD | -82.41% |
| 2018 Q3 | -339.83 Thousand USD | -123.62% |
| 2018 Q2 | -151.97 Thousand USD | -20.13% |
| 2018 Q1 | -126.5 Thousand USD | -152.82% |
| 2017 Q2 | -699.65 Thousand USD | -22.44% |
| 2017 Q1 | -571.4 Thousand USD | 29.71% |
| 2017 FY | - USD | -10.11% |
| 2017 Q4 | -50.03 Thousand USD | 98.07% |
| 2017 Q3 | -2.58 Million USD | -269.79% |
| 2016 Q1 | -646.15 Thousand USD | -549.7% |
| 2016 Q4 | -812.98 Thousand USD | -22.62% |
| 2016 FY | - USD | -136984.86% |
| 2016 Q3 | -663 Thousand USD | 21.99% |
| 2016 Q2 | -849.91 Thousand USD | -31.53% |
| 2015 Q4 | -99.45 Thousand USD | -314.89% |
| 2015 Q1 | -60.37 Thousand USD | -79.91% |
| 2015 Q3 | -23.97 Thousand USD | 33.63% |
| 2015 FY | - USD | 98.69% |
| 2015 Q2 | -36.11 Thousand USD | 40.18% |
| 2014 Q3 | -31.38 Thousand USD | -73.93% |
| 2014 FY | - USD | 17.63% |
| 2014 Q1 | -68 Thousand USD | -66.69% |
| 2014 Q2 | -18.04 Thousand USD | 73.47% |
| 2014 Q4 | -33.55 Thousand USD | -6.94% |
| 2013 Q3 | -53.08 Thousand USD | -39.64% |
| 2013 Q2 | -38.01 Thousand USD | -693.3% |
| 2013 Q4 | -40.79 Thousand USD | 23.15% |
| 2013 Q1 | -4792.44 USD | 93.11% |
| 2013 FY | - USD | 16.18% |
| 2012 FY | - USD | 42.21% |
| 2012 Q4 | -69.53 Thousand USD | 24.76% |
| 2012 Q3 | -92.41 Thousand USD | -35.29% |
| 2012 Q2 | -68.31 Thousand USD | 99.46% |
| 2012 Q1 | -12.72 Million USD | -201.55% |
| 2011 Q1 | -8.48 Million USD | -206.83% |
| 2011 Q2 | -142.5 Thousand USD | 98.32% |
| 2011 FY | - USD | 50.42% |
| 2011 Q4 | 12.53 Million USD | 13704.35% |
| 2011 Q3 | -92.12 Thousand USD | 35.36% |
| 2010 Q4 | 7.94 Million USD | 15127.51% |
| 2010 FY | - USD | -6734.64% |
| 2010 Q2 | -241.33 Thousand USD | -203.06% |
| 2010 Q3 | -52.85 Thousand USD | 78.1% |
| 2010 Q1 | 234.17 Thousand USD | 133.72% |
| 2009 FY | - USD | 99.94% |
| 2009 Q1 | -22.56 Million USD | -1302.53% |
| 2009 Q2 | -410.44 Thousand USD | 98.18% |
| 2009 Q3 | 451.86 Thousand USD | 210.09% |
| 2009 Q4 | 100.19 Thousand USD | -77.83% |
| 2008 FY | - USD | -731.33% |
| 2008 Q4 | 1.87 Million USD | 347.94% |
| 2008 Q1 | -646.93 Thousand USD | 12.85% |
| 2008 Q3 | -756.74 Thousand USD | -3.64% |
| 2008 Q2 | -730.15 Thousand USD | -12.86% |
| 2007 Q1 | -581.38 Thousand USD | -207.69% |
| 2007 FY | - USD | -81.66% |
| 2007 Q3 | -472.2 Thousand USD | 28.82% |
| 2007 Q4 | -742.3 Thousand USD | -57.2% |
| 2007 Q2 | -663.41 Thousand USD | -14.11% |
| 2006 FY | - USD | -53.26% |
| 2006 Q1 | -481.56 Thousand USD | -257.54% |
| 2006 Q2 | -275.01 Thousand USD | 42.89% |
| 2006 Q3 | -316.54 Thousand USD | -15.1% |
| 2006 Q4 | -188.95 Thousand USD | 40.31% |
| 2005 FY | - USD | -45.53% |
| 2005 Q2 | -240.41 Thousand USD | -7.1% |
| 2005 Q3 | -79.8 Thousand USD | 66.81% |
| 2005 Q4 | -134.68 Thousand USD | -68.77% |
| 2005 Q1 | -224.48 Thousand USD | -79.76% |
| 2004 Q3 | -215.36 Thousand USD | -181.03% |
| 2004 Q2 | -76.63 Thousand USD | 3.4% |
| 2004 Q1 | -79.33 Thousand USD | -40.26% |
| 2004 Q4 | -124.88 Thousand USD | 42.02% |
| 2004 FY | - USD | 0.0% |
| 2003 Q1 | -11.77 Thousand USD | 66.07% |
| 2003 Q4 | -56.56 Thousand USD | -104.69% |
| 2003 Q2 | -22.35 Thousand USD | -95.01% |
| 2003 Q3 | -27.63 Thousand USD | -20.37% |
| 2002 Q3 | -20.28 Thousand USD | 57.91% |
| 2002 Q4 | -26.49 Thousand USD | -71.04% |
| 2002 Q1 | -20.63 Thousand USD | 23.69% |
| 2002 Q2 | -48.19 Thousand USD | -133.57% |
| 2002 FY | - USD | 23.19% |
| 2001 FY | - USD | -1551.35% |
| 2001 Q3 | -21.63 Thousand USD | 0.0% |
| 2001 Q4 | -27.03 Thousand USD | -24.97% |
| 2000 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.89 Million USD | 100.0% |
| Polarean Imaging plc | -11.19 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 100.0% |
| Avitar, Inc. | -1.66 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.44 Million USD | 100.0% |
| QHSLab, Inc. | -91.29 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.35 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.0% |
| Escalon Medical Corp. | -58.46 Thousand USD | 100.0% |
| Aurora Spine Corporation | -454.37 Thousand USD | 100.0% |
| BrainsWay Ltd. | -2.31 Million USD | 100.0% |
| NewCardio, Inc. | -9.37 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.0% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.13 Million USD | 100.0% |
| Theraclion SA | -2.05 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 100.0% |
| Positron Corporation | -1.45 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 100.0% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.0% |
| ALR Technologies Inc. | -6.4 Million USD | 100.0% |
| Stratec SE | 39.91 Million USD | 100.0% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.55 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 100.0% |
| Ingen Technologies, Inc. | -8639.00 USD | 100.0% |
| Odyssey Group International, Inc. | -2.13 Million USD | 100.0% |
| United American Healthcare Corporation | -59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -2.99 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.0% |
| Urologix, Inc. | -6.34 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.0% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.0% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 100.0% |
| Smith & Nephew plc | 1 Billion USD | 100.0% |
| NIOX Group Plc | 11.07 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.83 Million USD | 100.0% |
| Broncus Holding Corporation | -25.19 Million USD | 100.0% |
| Brain Scientific Inc. | -7.93 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 100.0% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 100.0% |